INVO Fertility, Inc (NASDAQ:IVF – Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 533,091 shares, a growth of 87.3% from the February 12th total of 284,595 shares. Based on an average trading volume of 1,337,849 shares, the short-interest ratio is presently 0.4 days. Approximately 7.7% of the shares of the stock are short sold. Approximately 7.7% of the shares of the stock are short sold. Based on an average trading volume of 1,337,849 shares, the short-interest ratio is presently 0.4 days.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in INVO Fertility stock. Armistice Capital LLC acquired a new stake in INVO Fertility, Inc (NASDAQ:IVF – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 207,644 shares of the company’s stock, valued at approximately $156,000. Armistice Capital LLC owned about 8.69% of INVO Fertility as of its most recent filing with the SEC. Hedge funds and other institutional investors own 12.02% of the company’s stock.
Analyst Ratings Changes
IVF has been the subject of a number of analyst reports. Wall Street Zen raised INVO Fertility from a “sell” rating to a “hold” rating in a report on Saturday, March 7th. Maxim Group set a $4.00 target price on shares of INVO Fertility in a report on Tuesday, February 10th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, INVO Fertility presently has an average rating of “Moderate Buy” and an average target price of $4.00.
INVO Fertility Trading Down 5.1%
IVF opened at $0.82 on Friday. INVO Fertility has a 1-year low of $0.71 and a 1-year high of $94.64. The stock has a market capitalization of $5.69 million, a PE ratio of 0.00 and a beta of 2.66. The firm has a 50-day moving average price of $1.08 and a two-hundred day moving average price of $3.35.
INVO Fertility Company Profile
INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.
The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation.
Featured Stories
- Five stocks we like better than INVO Fertility
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for INVO Fertility Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Fertility and related companies with MarketBeat.com's FREE daily email newsletter.
